NZ195688A - 1-(8-quinolyl)-2-pyrrolidinone and pharmaceutical compositions - Google Patents

1-(8-quinolyl)-2-pyrrolidinone and pharmaceutical compositions

Info

Publication number
NZ195688A
NZ195688A NZ195688A NZ19568880A NZ195688A NZ 195688 A NZ195688 A NZ 195688A NZ 195688 A NZ195688 A NZ 195688A NZ 19568880 A NZ19568880 A NZ 19568880A NZ 195688 A NZ195688 A NZ 195688A
Authority
NZ
New Zealand
Prior art keywords
formula
compound
quinolyl
pyrrolidinone
process according
Prior art date
Application number
NZ195688A
Other languages
English (en)
Inventor
G L Hodgson Jr
T K Schumaker
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NZ195688A publication Critical patent/NZ195688A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ195688A 1979-11-30 1980-11-28 1-(8-quinolyl)-2-pyrrolidinone and pharmaceutical compositions NZ195688A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7941409 1979-11-30

Publications (1)

Publication Number Publication Date
NZ195688A true NZ195688A (en) 1984-09-28

Family

ID=10509524

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ195688A NZ195688A (en) 1979-11-30 1980-11-28 1-(8-quinolyl)-2-pyrrolidinone and pharmaceutical compositions

Country Status (18)

Country Link
US (1) US4366158A (enExample)
EP (1) EP0030023A3 (enExample)
JP (1) JPS5699475A (enExample)
KR (1) KR830004293A (enExample)
AR (1) AR228442A1 (enExample)
AT (1) AT375363B (enExample)
AU (1) AU6495080A (enExample)
CA (1) CA1156235A (enExample)
DK (1) DK506480A (enExample)
ES (1) ES8203882A1 (enExample)
FI (1) FI803704L (enExample)
GB (1) GB2063868B (enExample)
GR (1) GR71918B (enExample)
HU (1) HU185224B (enExample)
IL (1) IL61580A (enExample)
IT (1) IT1221040B (enExample)
NZ (1) NZ195688A (enExample)
ZA (1) ZA807467B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1558582T3 (pl) 2003-07-22 2006-05-31 Arena Pharm Inc Diarylowe i aryloheteroarylowe pochodne mocznika jako modulatory receptora serotoninowego 5-HT2A użyteczne w profilaktyce i w leczeniu zaburzeń związanych z tym receptorem
GB0507198D0 (en) * 2005-04-08 2005-05-18 Sb Pharmco Inc Process for preparing bicyclic compounds
GB0519758D0 (en) * 2005-09-28 2005-11-09 Glaxo Group Ltd Novel process
US9084742B2 (en) 2007-12-12 2015-07-21 Axovant Sciences Ltd. Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-Quinoline
WO2009123714A2 (en) 2008-04-02 2009-10-08 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
WO2010062321A1 (en) 2008-10-28 2010-06-03 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
MX388281B (es) 2015-06-12 2025-03-11 Axovant Sciences Gmbh Derivados de diaril y arilheteroaril urea como moduladores del receptor 5ht2a de serotonina útiles para la profilaxis y el tratamiento de un trastorno conductual del sueño rem.
CA2992518A1 (en) 2015-07-15 2017-01-19 Axovant Sciences Gmbh Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease

Also Published As

Publication number Publication date
AT375363B (de) 1984-07-25
IT1221040B (it) 1990-06-21
IL61580A (en) 1984-06-29
IT8050277A0 (it) 1980-11-28
DK506480A (da) 1981-05-31
ES497242A0 (es) 1982-04-01
ES8203882A1 (es) 1982-04-01
GR71918B (enExample) 1983-08-17
AR228442A1 (es) 1983-03-15
FI803704A7 (fi) 1981-05-31
IL61580A0 (en) 1980-12-31
HU185224B (en) 1984-12-28
EP0030023A3 (en) 1981-09-02
KR830004293A (ko) 1983-07-09
ATA582780A (de) 1983-12-15
JPS5699475A (en) 1981-08-10
EP0030023A2 (en) 1981-06-10
GB2063868A (en) 1981-06-10
FI803704L (fi) 1981-05-31
US4366158A (en) 1982-12-28
CA1156235A (en) 1983-11-01
GB2063868B (en) 1984-02-29
AU6495080A (en) 1981-06-04
ZA807467B (en) 1982-07-28

Similar Documents

Publication Publication Date Title
US4022776A (en) 5-[1-Hydroxy-2-(substituted-amino)]ethyl-8-hydroxycarbostyril derivatives
US4042700A (en) Quaternary N-β-substituted N-alkyl-nortropine benzilates
SU820659A3 (ru) Способ получени производных 4-амино- 5-АлКилСульфОНилОАНизАМидОВ, иХ СОлЕй,ОКиСЕй, лЕВО- и пРАВОВРАщАющиХизОМЕРОВ /иХ ВАРиАНТы/
EP0147719B1 (en) Novel carbostyril derivative and process for preparing same
EP0689536B1 (en) Naphthalene derivatives
GB1604674A (en) Aminoalkyl-benzene derivatives
CA2061557A1 (en) New benzene derivatives having ngf production-promoting activity
KR850000216B1 (ko) 피페라진 유도체의 제조방법
EP0228959B1 (en) Aminostyryl compound, leukotriene antagonistic composition containing the same as effective ingredients and method of antagonizing srs by employing the same
US4366158A (en) 1-(8-Quinolyl)-2-pyrrolidone and its pharmaceutical compositions
EP0219961B1 (en) Irreversible dopamine-b-hydroxylase inhibitors
EP0089900B1 (en) New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts
US4435396A (en) Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor
JPH0655739B2 (ja) 新規８α‐アシルアミノエルゴリン類
US4670439A (en) 2H-1-benzopyran-2-one derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
US4623648A (en) 1-azaxanthone for use as therapeutic agent as an antipyretic, analgesic, anti-inflammatory and bronchodilator
US4183937A (en) Blood pressure lowering benzoquinolizines
EP0279398B1 (en) Antifungal 2-anilinothiazolines
EP0270692A1 (en) Antiarrhythmic agent
EP0559190A1 (en) Substituted N- 3- 3-(1-piperinomethyl)-phenoxy propyl actamides as antiuocer drugs
GB1588469A (en) 1-substituted-3-w-aminoalkoxy)pyrrolidines
CA1133913A (en) N-(1-methyl-2-pyrrolidinyl-methyl)-2,3- dimethoxy-5-methylsulphamoyl benzamide and its derivatives, their preparation processes and their use in the treatment of disorders of the lower urinary apparatus
US4126625A (en) Certain 5-substituted-3-methyl-2-benzofuran acetic acids
US4690933A (en) Pyridylvinyl-1H tetrazole having antihistamine activity
EP0171912B1 (en) Pyrrolizidine compounds, methods for their production, and their uses